Page last updated: 2024-12-08

atranol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

atranol: an oak moss allergen [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID458186
CHEMBL ID223288
CHEBI ID144118
SCHEMBL ID3185655
MeSH IDM0477531

Synonyms (18)

Synonym
atranol
benzaldehyde, 2,6-dihydroxy-4-methyl-
2,6-dihydroxy-4-methyl-benzaldehyde
p-orsellinaldehyde
CHEMBL223288
2,6-dihydroxy-4-methylbenzaldehyde
FT-0693051
CHEBI:144118
526-37-4
AKOS006292139
SCHEMBL3185655
JASONGFGOLHLGB-UHFFFAOYSA-N
atranol, analytical reference material
DTXSID10200574
orcal
EN300-314017
CS-0245956
Z1198164603

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" decussata and their plasma-related bioavailability were also investigated using LC-ESI-MS/MS."( New Insights into the Biological Activity of Lichens: Bioavailable Secondary Metabolites of Umbilicaria decussata as Potential Anticoagulants.
Javad Davarpanah, S; Vaez, M, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves were estimated and analysed by logistic regression."( Comparison of elicitation potential of chloroatranol and atranol--2 allergens in oak moss absolute.
Andersen, KE; Bernard, G; Bruze, M; Giménez-Arnau, E; Johansen, JD; Lepoittevin, JP, 2006
)
0.59
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxybenzaldehyde
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID283977Antibacterial activity against Staphylococcus aureus2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Synthesis of diverse analogues of Oenostacin and their antibacterial activities.
AID283976Antibacterial activity against Staphylococcus epidermidis2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Synthesis of diverse analogues of Oenostacin and their antibacterial activities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (40.00)29.6817
2010's6 (40.00)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.24 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index39.83 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (13.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]